Ipilimumab

Inquire / Price
  • Model Number:
    RL602025122504
  • Brand Name:
    达伯欣®
  • Origin:
    Biosimilars,china
  • Small Orders:
    Small batches also available
  • Tags:
Inquire Now Link

Poster
  • Details
  • Description
  • Packaging Size
    1 Bottle
  • Strength
    50mg(10ml)
  • Compositon
    Ipilimumab
  • Treatment
    Microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) CRC
  • Form
    Injection
  • Brand
    达伯欣®
  • Quantity Unit
    50mg(10ml)*1Bottle/box
  • Manufacturer
    Innovent Bio,China

About Ipilimumab

Ipilimumab is a monoclonal antibody medication that works to activate the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system. Ipilimumab. Fab fragment of ipilimumab (blue) binding CTLA-4 (green).

Colorectal Cancer (CRC)

Indicated in combination with nivolumab for treatment of unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) CRC

1 mg/kg IV every 3 weeks PLUS nivolumab 240 mg IV every 3 weeks for maximum of 4 doses

Refer to nivolumab prescribing information for continuation as monotherapy


Link

Poster

Top